Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Feb / An Injection of Infection
Biochemistry and molecular biology Molecular Pathology

An Injection of Infection

Research shines a light on the molecular “syringes” of certain bacteria

By George Francis Lee 02/06/2024 News 2 min read

Share

Salmonella, Shigella, and Yersinia and other bacteria are known for their secretion systems through which they inject and manipulate eukaryotic cells. This type-III secretion (T3SS), also known as the “injectisome,” is vital for the bacteria’s virulence and spread. But how does this mechanism work on a molecular level? Researchers from the Max Planck Institute for Terrestrial Microbiology, Germany, have uncovered some molecular details that make this biological task possible.

“Although we know a lot about this system, especially its evocative syringe-like structure, the key question of how the system recruits its effectors was unknown,” says Andreas Diepold, Research Group Leader of the study.

“The reason that we didn’t know how the T3SS recruits its effectors to the injectisome is that interactions of proteins in secretion systems are (almost by definition) transient – the secreted proteins need to bind, but then also need to be quickly released for export,” he adds.

The team were able to overcome this roadblock by using new methods to observe the injectisome in situ, including proximity labeling and single molecule localization microscopy (SMLM, which tracks fluorescence-activated molecules in the target cell using high-speed cameras to produce super-resolution images).

“For proximity labeling, a protein of interest is fused to an enzyme that activates biotin, which then quickly binds to the nearest protein,” Diepold explains. “We can then purify the biotinylated proteins and see which proteins are in the proximity of our protein of interest.”

These techniques, explains Diepold, allowed the team to discover a “shuttle service” that ensures that the required proteins are delivered from bacterial cytosol to the injectisome at the correct moment.

The proteins shuttled within T3SS are dynamic and already known to researchers, but it was thanks to proximity labeling that the researchers could confirm that the proteins interact with two of the dynamic T3SS components.

“We then used SMLM to see where this happens,” Diepold explains. “We found that, in presence of the correct cargo, the shuttle molecules were slower, indicating that these proteins interact in the cytosol before being delivered to the injectisome.”

In light of growing antibiotic resistance, there exists hope that disrupting the T3SS process through anti-virulence drugs could become a viable option for disease prevention.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. S Wimmi et al., “Cytosolic sorting platform complexes shuttle type III secretion system effectors to the injectisome in Yersinia enterocolitica,” Nat Microbiol (2024).

About the Author(s)

George Francis Lee

Interested in how disease interacts with our world. Writing stories covering subjects like politics, society, and climate change.

More Articles by George Francis Lee

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Turning Tides
Biochemistry and molecular biology
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

Molecular Spectacular
Biochemistry and molecular biology
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

qPCR Infectious Disease Detective
Biochemistry and molecular biology
qPCR: Infectious Disease Detective

January 4, 2024

3 min read

How quantitative polymerase chain reaction really hits the mark in epidemic control and ID detection

Case of the Month
Biochemistry and molecular biology
Case of the Month

January 11, 2022

1 min read

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.